Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Fresh Competition Coming For Narcan In US

Amphastar Receives Approval For 505(b)(2) Naloxone As Amneal Files Generic

Narcan 4mg spray — More rivals to Narcan are being approved and reviewed by the FDA • Source: Shutterstock

Related Content

Urgency For Approval Of OTC Naloxone In US Weighed Against Using Untested Package Labeling

Feb 16 2023

After US FDA Advisors Unanimously Back First OTC Naloxone Proposal, Meeting On Second Not Needed

Mar 01 2023

Adamis Receives FDA Approval For 505(b)(2) Naloxone

Oct 21 2021

Hikma Launches Nasal Naloxone Spray In US

Aug 05 2021

Teva Sees Off Emergent’s US Narcan Appeal In ‘A Close Case’

Feb 14 2022

Padagis Introduces Fresh Narcan Rival In US

Jun 23 2022

Related Companies

Amphastar Pharmaceuticals, Inc.

Amneal Pharmaceuticals, Inc.

Additional Topics

United States Approvals Value-Added Medicines Generic Drugs BioPharmaceutical

More from Products

More from Generics Bulletin

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window